This reader stabilizes transcripts of MYC and VEGFA in an m6A modification‐dependent manner, both of which subsequently interact with the downstream effector IGF2BP2 to establish a strong axis in GBM. The gene discussed is IGF2BP2; the disease is glioblastoma.